Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer

Clinical trial NCT04592211 · RECRUITING

Trial details

NCT number: NCT04592211
Sponsor: Yonsei University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastric Cancer Stage IV

Start date: 2021-10-01
Primary completion: 2025-12-31
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.